Education
About Us
Working with TipRanks
Follow Us
Torrent Pharmaceuticals Ltd (IN:TORNTPHARM)
:TORNTPHARM
TORNTPHARM Stock Chart & Stats
₹3578.85
-₹79.35(-2.33%)
At close: 4:00 PM EST
₹3578.85
-₹79.35(-2.33%)
Day’s Range― - ―
52-Week Range₹2,891.45 - ₹3,880.55
Previous CloseN/A
Volume167.59K
Average Volume (3M)10.10K
Market Cap
₹1.28T
Enterprise Value₹1.24T
Total Cash (Recent Filing)₹6.88B
Total Debt (Recent Filing)₹0.00
Price to Earnings (P/E)59.9
Beta0.65
Next Earnings
Jan 22, 2026EPS Estimate
17.66Next Dividend Ex-DateN/A
Dividend Yield0.84%
Share Statistics
EPS (TTM)17.70
Shares Outstanding338,431,850
10 Day Avg. Volume3,987
30 Day Avg. Volume10,095
Financial Highlights & Ratios
PEG Ratio3.66
Price to Book (P/B)14.19
Price to Sales (P/S)9.36
P/FCF Ratio54.58
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)72.84
Revenue Forecast (FY)₹130.04B
Torrent Pharmaceuticals Ltd News
TORNTPHARM FAQ
What was Torrent Pharmaceuticals Ltd’s price range in the past 12 months?
Torrent Pharmaceuticals Ltd lowest stock price was ₹2891.45 and its highest was ₹3880.55 in the past 12 months.
What is Torrent Pharmaceuticals Ltd’s market cap?
Torrent Pharmaceuticals Ltd’s market cap is ₹1.28T.
When is Torrent Pharmaceuticals Ltd’s upcoming earnings report date?
Torrent Pharmaceuticals Ltd’s upcoming earnings report date is Jan 22, 2026 which is in 37 days.
How were Torrent Pharmaceuticals Ltd’s earnings last quarter?
Torrent Pharmaceuticals Ltd released its earnings results on Nov 07, 2025. The company reported ₹17.7 earnings per share for the quarter, missing the consensus estimate of ₹18.262 by -₹0.562.
Is Torrent Pharmaceuticals Ltd overvalued?
According to Wall Street analysts Torrent Pharmaceuticals Ltd’s price is currently Overvalued.
Does Torrent Pharmaceuticals Ltd pay dividends?
Torrent Pharmaceuticals Ltd pays a Notavailable dividend of ₹6 which represents an annual dividend yield of 0.84%. See more information on Torrent Pharmaceuticals Ltd dividends here
What is Torrent Pharmaceuticals Ltd’s EPS estimate?
Torrent Pharmaceuticals Ltd’s EPS estimate is 17.66.
How many shares outstanding does Torrent Pharmaceuticals Ltd have?
Torrent Pharmaceuticals Ltd has 338,431,850 shares outstanding.
What happened to Torrent Pharmaceuticals Ltd’s price movement after its last earnings report?
Torrent Pharmaceuticals Ltd reported an EPS of ₹17.7 in its last earnings report, missing expectations of ₹18.262. Following the earnings report the stock price went up 0.703%.
Which hedge fund is a major shareholder of Torrent Pharmaceuticals Ltd?
Currently, no hedge funds are holding shares in IN:TORNTPHARM
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Torrent Pharmaceuticals Ltd
Torrent Pharmaceuticals Limited engages in the research, development, manufacturing, and marketing of generic pharmaceutical formulations in India, the United States, Germany, Brazil, and internationally. It offers products in various therapeutic areas, including cardiovascular, central nervous system, gastrointestinal, women healthcare, diabetology, pain management, gynecology, oncology, and anti-infective, as well as provides vitamins, minerals, and nutrients. The company also provides contract manufacturing services. It has licensing collaborations of Baricitinib, Molnupiravir, and Paxlovid for its Covid portfolio. Torrent Pharmaceuticals Limited was formerly known as Trinity Laboratories and changed its name to Torrent Pharmaceuticals Limited in 1971. The company was founded in 1959 and is based in Ahmedabad, India. Torrent Pharmaceuticals Limited is a subsidiary of Torrent Investments Private Limited.
Technical Analysis
Cipla Ltd
―
Divi's Laboratories Limited
―
Dr. Reddy's Laboratories Ltd.
―
Lupin Limited
―
Zydus Lifesciences Limited
―